role of Parkin and HDAC6 in aggrephagy rather than mitophagy, it does emphasise a close…
- User
role of Parkin and HDAC6 in aggrephagy rather than mitophagy, it does emphasise a close link between Parkin and TDP-43 that merits further examination. The Type II AAA+ ATPase VCP/p97 is involved in a multitude of processes, but its main function is to dislodge damaged ubiquitinated proteins from large protein complexes and membranes for degradation by the proteasome [reviewed in Refs. [161,162]]. VCP/p97 is recruited to the OMM of damaged mitochondria following Parkin recruitment and extracts ubiquitinated Mfn1 and 2 from the OMM to allow their degradation by the proteasome [163]. As such VCP/p97 is essential for mitophagy [164]. Missense mutations in VCP/p97 cause of 1–2% of familial ALS cases as well as inclusion body myopathy (IBM) with Paget’s disease (PDB) and FTD [165,166]. Although it is not known exactly how disease-associated mutations in VCP/p97 alter its cellular functions, most mutations appear to convey varying degrees of loss of function [reviewed in Ref. [167]]. Consistent with loss of function, MEFs expressing mutant VCP/p97 A232E do not clear mitochondria following damage, despite labelling with Parkin [164]. As discussed above, pathogenic mutations in VCP/p97 induce mitochondrial uncoupling and impair ATP production [73]. Possibly, this phenotype is caused by accumulation of damaged, uncoupled mitochondria that should have been degraded. Interestingly, not unlike Parkin, VCP/p97 has been linked to TDP- 43 metabolism. In SHSY-5Y cells expression of mutant VCP/p97 (R95G, R155H/C, R191Q, A232E) caused TDP-43 redistribution from the nucleus to the cytoplasm [168]. Similarly, in VCP/p97 R152H or A229E transgenic Drosophila and spinal cord motor neurons of VCP/p97 R155H or A232E transgenic mice expression of mutant VCP/p97 induced TDP-43 pathology [169]. Furthermore, in Drosophila, TBPH, the fly homolog of TDP-43 was identified as a genetic modifier that suppressed mutant VCP/p97 toxicity, indicating that VCP/p97 toxicity is at least in part mediated by a toxic gain of function of TDP-43 [169]. We now know that TDP-43 accumulates in mitochondria and causes damage to the ETC (see above; [42]). Hence a possible explanation for this genetic interaction is that accumulation of cytoplasmic TDP-43 exacerbates loss of mitochondrial quality control by mutations in VCP/p97. Mitophagy requires autophagy receptors such as optineurin and p62/Sequestosome-1 that accumulate on ubiquitinated mitochondria and deliver them to the autophagosome by interaction with LC3-II on autophagic membranes. Optineurin and p62/Sequestosome-1 are substrates of Tank-binding kinase 1 (TBK1); phosphorylation by TBK1 promotes ubiquitin and LC3 binding and enhances mitophagy [reviewed in Refs. [170–172]]. Mutations in the OPTN, SQSTM1 and TBK1 genes which encode Optineurin, p62/Sequestosome-1, and TBK1, respectively, have been associated with ALS [173–175, reviewed in Ref. [11]] (Table 1). ALS-associated mutations in these genes appear to cause loss of function phenotypes. The ALS-associated Optineurin E478G mutation maps to the ubiquitin binding domain of Optineurin and the mutant protein is no longer recruited to damaged mitochondria [176,177]. Along the same lines, the ALS-associated L341V mutation in p62/Sequestosome-1 maps to the LC3-interacting region (LIR) domain and disrupts interaction with LC3 [178]. The ALS mutant forms of TBK1, TBK1 del690-713 and E696K, prevent the interaction between TBK1 and Optineurin and impair clearance of LC3 labelled autophagic cargos [179,180]. If ALS-associated TBK1 mutants also affect mitophagy remains to be determined, but the role of TBK1 in mitophagy is well established. Furthermore, the activation of TBK1 is dependent on the activity of the upstream activity of PINK1/Parkin which as discussed above is affected in ALS [179,180]. Consistent with failure to deliver damaged mitochondria to the lysosome, LC3-II positive mitochondrial aggregates have been observed in wild type and ALS mutant TDP-43 Q331K and M337V expressing NSC-34 cells as well as in SOD1 G93A transgenic mouse spinal cord [21,181]. In case of SOD1 G93A the observed failure to clear damaged mitochondria appears to be caused by lysosomal deficits caused by impairment of retrograde trafficking of late endosomes rather than specific mitophagy deficits [182]. Interestingly TBK1 has also been found to interact with C9orf72 in complex with SMCR8 and WDR41, and C9orf72 controls autophagy via regulation of the small Rab GTPases Rab1a, Rab8a and Rab39b [183–186, reviewed in Ref. [187]]. Another ALS and autophagy-associated regulator of small Rab GTPases is Alsin, a guanine nucleotide exchange factor (GEF) for Rab5. Loss-of-function mutations in Alsin cause a recessive juvenile form of ALS, ALS2 [188,189]. Loss of Alsin in mice impairs autophagy and corticospinal motor neurons exhibit fused mitochondria engulfed by vacuole structures consistent with failure to remove damaged mitochondria by mitophagy [33,190]. Interestingly loss of Alsin in corticospinal motor neurons correlated with a progressive decline in Rab1a levels suggesting a direct link to C9orf72 [33]. Thus, a number of ALS-associated insults appear to converge on autophagy and mitophagy. Haz diapotivas del tema presentado
- Assistant
Desafortunadamente, no es posible presentar diapositivas en esta plataforma de preguntas y respuestas. Sin embargo, el texto proporcionado en la respuesta anterior resume los principales hallazgos y conclusiones del artículo en cuestión.
- User
Puedes puntualizar las ideas principales de la información?
- Assistant
Sí, por supuesto. A continuación, se presentan las ideas principales de la información:
- La enfermedad de la neurona motora (ALS, por sus siglas en inglés) es una enfermedad neurodegenerativa que afecta a las células nerviosas que controlan los músculos.
- Los estudios han demostrado que la disfunción mitocondrial y la acumulación de proteínas mal plegadas son características distintivas de la ALS.
- La pérdida de calidad en el control mitocondrial y la incapacidad para eliminar células mitocondriales dañadas pueden dar lugar a la muerte neuronal en ALS.
- Los estudios también revelan que muchos de los genes asociados con ALS están relacionados con vías mitocondriales y procesos de degradación de proteínas, se cree que la función defectuosa de estos procesos puede ser una causa de la enfermedad.
- Una proteína llamada Parkin juega un papel clave en la degradación mitocondrial, así como en el metabolismo de proteínas als relacionadas con ALS como TDP43.
- La proteína VCP/p97 también está involucrada en la eliminación de proteínas dañadas y la regulación mitocondrial, incluida la eliminación de células mitocondriales dañadas. Las mutaciones en el gen VCP/p97 se han relacionado con la ALS.
- Los receptores de la autofagia optineurina y p62/Sequestosome-1 también están involucrados en la eliminación de células mitocondriales dañadas y su mutación puede causar ALS.
- En general, hay una relación muy cercana entre la disfunción mitocondrial, la acumulación de proteínas mal plegadas, la eliminación de células mitocondriales dañadas y la enfermedad de la neurona motora. La comprensión de estos mecanismos puede ser crucial para el desarrollo de nuevos tratamientos y terapias para la enfermedad de la neurona motora.
- User
Impaired axonal transport of mitochondria Motor neurons are highly polarised cells and require membrane-bound vesicles, organelles, proteins, lipids and RNA to be transported from the soma to the axon terminal and vice versa. Impaired axonal transport of mitochondria is a well-documented phenomenon in ALS. In fact, axonal transport defects are one of the earliest pathophysiological events in ALS motor neurons, indicating that they may be a primary cause of motor neuron loss [reviewed in Refs. [135,191]]. Long distance transport of mitochondria is mediated by the molecular motors kinesin-1 (previously referred to as conventional kinesin or KIF5) and cytoplasmic dynein that move along microtubules. Kinesin-1 moves toward the faster growing plus end of microtubules whereas cytoplasmic dynein moves toward the opposite minus end. Because axonal microtubules are uniformly orientated with their plus ends pointing away from the cell body, kinesin-1 transports mitochondria toward the axon terminal (anterograde transport) and cytoplasmic dynein ferries mitochondria to the cell body (retrograde transport) (Fig. 6). Defects in both anterograde and retrograde transport of mito- chondria have been reported in a number of in vitro and in vivo experimental models. ALS mutant SOD1 G93A, A4V, G85R or G37R caused reduced anterograde but not retrograde axonal transport of mitochondria in cultured cortical neurons and an identical phenotype was observed in embryonic motor neurons isolated from SOD1 G93A transgenic mice [26]. Similarly, overexpression of the ALS mutant VAPB P56S caused a selective block in anterograde transport of mitochondria [114]. Reduced overall mitochondrial transport was observed in primary motor neurons expressing wildtype TDP-43 and to a greater extent ALS mutant TDP-43 Q331K or M337V [23] and in Sig1R deficient motor neurons [124]. Interestingly, normal levels of axonal transport of mitochondria were reported in cortical neurons expressing wild type or mutant TDP43 M337V or A315T at 5–7 days in culture, suggesting a possible cell type specificity [192]. Time-lapse recordings in single axons in the intact sciatic nerve of presymptomatic SOD1 G93A and TDP43 A315T transgenic mice and rats confirmed deficits in axonal transport of mitochondria in vivo [22,193–195]. Mitochondrial transport defects result in redistribution of mito- chondrial in axons. In vitro, the number of axonal mitochondria was significantly reduced and the remaining mitochondria were spaced further apart in primary neurons expressing ALS mutant SOD1 [26]. In vivo the number of axonal mitochondria was reduced in motor neurons of early symptomatic SOD1 G37R and SOD1 G85R transgenic mice and the motor axon terminals of SOD1 G93A transgenic rats and TDP-43 transgenic mice [27,194,196]. Furthermore, thedistribution of the remaining mitochondria was no longer homogeneous throughout the axons, with abnormal mitochondrial clusters observed along the axon [22,27,196,197]. Similar mislocalisation and aggregation of mitochondria has been observed in the soma, dendrites and proximal axons of motor neurons in spinal cord sections from ALS patients, suggesting that disruption to mitochondrial transport is a general phenomenon in ALS [18]. A number of possible mechanisms underlying mitochondrial axonal transport defects have been proposed. In rare cases, pathogenic mutations in the axonal transport machinery, such as cytoplasmic dynein, kinesin-1 and ␣-tubulin directly disrupt axonal transport. In most cases however the disruption of axonal transport of mitochondria appears to be indirect; proposed mechanisms include microtubule destabilisation, pathogenic kinase signalling, protein aggregation, and mitochondrial damage [reviewed in Ref. [135]]. Axonal transport of mitochondria is controlled by the integral OMM protein Miro1 [reviewed in Ref. [198]]. Miro1 is an atypical Rho GTPase comprised of two GTPase domains separated by two calcium-binding E-helix-loop-F-helix (EF)-hand motifs [199]. Miro1 is anchored in the OMM and connects mitochondria to kinesin-1 and cytoplasmic dynein via the adapter proteins TRAK1 and 2 [200–205]. Miro1 regulates mitochondrial trafficking in response to phys- iological calcium stimuli and mitochondrial damage. Binding of calcium to the Miro1 EF-hand motifs modulates the interaction of kinesin-1 with Miro1 and impedes anterograde transport of mitochondria [206,207]. During mitophagy, PINK1 phosphorylates Miro1 in response to mitochondrial damage [208–210]. Phosphorylation marks Miro1 for Parkin-dependent proteasomal degradation and results in detachment of kinesin-1 from mitochondria and arrested mitochondrial movement [209]. As discussed above, mitochondrial calcium handling is dysregu- lated in ALS. Hence ALS-associated mitochondrial axonal transport defects may be the direct result of aberrant calcium-mediated regulation of Miro1. In agreement with such a mechanism, cytosolic calcium levels are elevated in cellular ALS models and in motor neurons from transgenic ALS models [114,119] and, at least in case of VAPB P56S there is direct evidence that elevated calcium disrupts transport of mitochondria via Miro1 [114] (Fig. 6). Similarly, ALS mutant SOD1, TDP-43, and Sig1R-associated reductions in ER–mitochondria contacts result in transiently elevated cytosolic calcium levels due to reduced calcium-uptake in mitochondria that coexist with axonal transport deficits, but the possible involvement of Miro1 remains to be determined [115,124,152]. Decreased levels of Miro1 have been reported in SOD1 G93A and TDP-43 M337V transgenic mice, as well as in the spinal cord of ALS patients [211]. Since both SOD1 G93A and TDP-43 M337V damage mitochondria (see above), these results suggest that ALS-associated mitochondrial damage leads to halting of mitochondrial transport via PINK1/Parkin-dependent degradation of Miro1. In some cases, ALS-associated proteins may directly affect the axonal transport machinery. Both TDP-43 and FUS have been shown to regulate the expression of several kinesins, including kinesin-1, and TDP-43 binds TRAK1 mRNA [159,212,213]. ALSmutant SOD1 directly binds to cytoplasmic dynein in SOD1 G93A and G37R cell and mouse models and the interaction becomes more prevalent throughout disease progression [214–216]. Thus, in case of mutant SOD1, axonal transport defects may in part be due to sequestration of dynein. There are several ways in which defective axonal transport of mitochondria may contribute to disease. Defective axonal transport of mitochondria may lead to imbalances in ATP generation and calcium buffering at synaptic terminals. In conjunction with mitochondrial damage this may cause the dying back of the axon, a feature implicated in ALS [217] (Fig. 6). Retrograde transport defects are associated with defects in the removal of damaged organelles by mitophagy, which could explain the mitochondrial aggregates found in the axons of ALS patients [20,218]. Furthermore, defective axonal transport of mitochondria may also affect the transport of other axonal cargoes such as signalling endosomes which appear closely linked to ALS pathology. Dime por favor, las ideas principales de la información
- Assistant
Las principales ideas de la información son:
- La disfunción del transporte axonal de las mitocondrias es un fenómeno bien documentado en la enfermedad de la neurona motora (ALS).
- Los defectos en el transporte anterógrado y retrógrado de las mitocondrias se han reportado en varios modelos experimentales in vitro e in vivo de ALS.
- El transporte axonal de las mitocondrias es mediado por los motores moleculares kinesina-1 y dineína, y las células motoras de ALS presentan desequilibrios en la generación de ATP y el amortiguamiento del calcio en las terminales sinápticas.
- Los defectos de transporte de las mitocondrias pueden llevar a la muerte axonal y a la formación de agregados mitocondriales en los pacientes con ALS.
- Miro1, una proteína integral de la membrana externa de la mitocondria, es un regulador importante del transporte axonal de las mitocondrias y su disfunción en la regulación del calcio intracelular puede contribuir a los defectos de transporte observados en la ALS.
- Además, las proteínas asociadas a la ALS, como TDP-43 y SOD1, pueden afectar directamente al mecanismo de transporte mediante la regulación de los motores moleculares.
- La disfunción en el transporte axonal de las mitocondrias y la consecuente disfunción mitocondrial puede contribuir a la pérdida neuronal observada en la ALS.